A bioreactor dispenses a controlled environment. This controlled environment is essential for the manufacturing of biological, biochemical and biomechanically engineered products. A bioreactor can be defined as a vessel, container, or a tank that performs the function of a biological catalyst to achieve a required chemical transformation from biological raw materials. Microorganisms are used in various industries and require molecular oxygen for respiration for survival. Optimization is important for the growth of organisms in a desired manner and for production of the required product at a sufficient rate. These organisms include species of bacteria, yeast, and mold. These organisms need and depend on a solution of oxygen or a mass transfer from a gaseous stream. This can be either in the form of air or oxygen introduced into the liquid in the bioreactor. A bioreactor invariably forms the core of all processes which involve enrichment of organisms.

Bioreactors have been used for a long time in the production of high-value products and therapeutic biomolecules. These devices control and monitor the environmental conditions consistently, throughout the ongoing reaction of the culture. This happens in a closed system. High productivity is achieved by the accurate design and appropriate selection of the bioreactor. This in turn helps to achieve corresponding capital investment and improves the economic viability of bioprocess. The basic characteristics of a bioreactor include headspace volume, oxygen delivery system, agitator system, temperature & pH control system, foam control, sampling ports, lines for charging & emptying the reactor, and cleaning & sterilization system. Bioreactors are dependent on temperature control. It is important to choose a proper temperature control device based on the specific needs of each application by calculating the heat load. A well-designed bioreactor should provide better productivity and validation of desired factors toward obtaining higher quality products and in a cost effective manner. The mode of operation as well as the design of a bioreactor depends on optimum conditions for product, its formation, production of organism, product value, and scale of production. An ideal bioreactor controls and allocates a positive influence on the biological reaction preventing foreign acquired contamination. Operating cost and capital investment are key points to be taken into consideration while designing a bioreactor.

The global bioreactors market is driven by high investments in R&D, rise in acceptance of single-use bioreactors, technological advancements in bioreactors, and rapid growth of the pharmaceutical and biotechnology industry. However, availability and access to various alternative techniques for bioreactors and uncompromising regulatory framework for the device and materials used are the major restraints of the global bioreactors market.

The global bioreactors market can be segmented based on material, usage, capacity, and end-user. In terms of material, the bioreactors market can be categorized into stainless steel, glass, and others. Based on usage, the global bioreactors market can be classified into pilot scale production, large scale production, and full scale production. In terms of capacity, the bioreactors market can be divided into above 1500L, 200L–1500L, 20L–200L, and 5L–20L. Based on end-user, the global bioreactors market can be categorized into biopharmaceutical companies, research organization, and others. Growth of biotechnological companies and increase in focus on research funding offered by governments are the factors expected to drive the end user segment during the forecast period.

Geographically, the global bioreactors market can be segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are expected dominate the global bioreactors market due to presence of large number of biopharmaceutical manufacturing companies.

Key players operating in the global bioreactors market are Thermo Fisher Scientific, Inc., Merck KGaA, Pall Corporation, ZETA Holding GmbH, Sartorius AG, Hipurity Systems Limited, Bioengineering AG, Infors AG, Applikon Biotechnology, Eppendorf AG, and M+ W Group, among others.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

The study is a source of reliable data on:

  • Market segments and sub-segments
  • Market trends and dynamics
  • Supply and demand
  • Market size
  • Current trends/opportunities/challenges
  • Competitive landscape
  • Technological breakthroughs
  • Value chain and stakeholder analysis

The regional analysis covers:

  • North America (U.S. and Canada)
  • Latin America (Mexico, Brazil, Peru, Chile, and others)
  • Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
  • Eastern Europe (Poland and Russia)
  • Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
  • Middle East and Africa (GCC, Southern Africa, and North Africa)

The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.

A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.

Highlights of the report:

  • A complete backdrop analysis, which includes an assessment of the parent market
  • Important changes in market dynamics
  • Market segmentation up to the second or third level
  • Historical, current, and projected size of the market from the standpoint of both value and volume
  • Reporting and evaluation of recent industry developments
  • Market shares and strategies of key players
  • Emerging niche segments and regional markets
  • An objective assessment of the trajectory of the market
  • Recommendations to companies for strengthening their foothold in the market   

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.


Bioreactors Market

Pre Book